Literature DB >> 2901413

Bordetella pertussis adenylate cyclase. Identification of multiple forms of the enzyme by antibodies.

A Rogel1, Z Farfel, S Goldschmidt, J Shiloach, E Hanski.   

Abstract

Two forms of Bordetella pertussis adenylate cyclase of 200 and 47 kDa have been purified from dialyzed urea extract of the bacteria to specific activities of 466 and 1685 mumol.min-1.mg-1, respectively. Both forms are activated 50-200-fold by calmodulin. The half-maximum concentration required for the activation of the 200-kDa catalyst is 5.4.10(-9) M, whereas the one required for activation of the 47-kDa catalyst is 1.8.10(-10) M. Polyclonal antibodies raised against the 47-kDa catalyst specifically recognize both forms of the enzyme in purified state as well as in bacterial extracts on immunoblots. The antibody inhibits at similar titer adenylate cyclase activity of the purified forms as well as the activity present in dialyzed urea extract of the bacteria. It also prevents the penetration of the invasive B. pertussis adenylate cyclase into human lymphocytes. The inhibition induced by the antisera is specific to B. pertussis enzyme, since both calmodulin-dependent brain and sperm adenylate cyclase are not affected by the antibody.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901413

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.

Authors:  S J Lee; M C Gray; L Guo; P Sebo; E L Hewlett
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 2.  Cyclic AMP in prokaryotes.

Authors:  J L Botsford; J G Harman
Journal:  Microbiol Rev       Date:  1992-03

3.  Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase.

Authors:  J Bellalou; H Sakamoto; D Ladant; C Geoffroy; A Ullmann
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

4.  Bordetella pertussis adenylate cyclase inactivation by the host cell.

Authors:  A Gilboa-Ron; A Rogel; E Hanski
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

5.  Synthesis and secretion of Bordetella pertussis adenylate cyclase as a 200-kilodalton protein.

Authors:  J Bellalou; D Ladant; H Sakamoto
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

6.  Adenylate cyclase toxin of Bordetella pertussis: production, purification, and partial characterization.

Authors:  M S Leusch; S Paulaitis; R L Friedman
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

7.  Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion.

Authors:  M Mouallem; Z Farfel; E Hanski
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

8.  Mutagenesis of Bordetella pertussis with transposon Tn5tac1: conditional expression of virulence-associated genes.

Authors:  B T Cookson; D E Berg; W E Goldman
Journal:  J Bacteriol       Date:  1990-04       Impact factor: 3.490

9.  The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies.

Authors:  Xianzhe Wang; Mary C Gray; Erik L Hewlett; Jennifer A Maynard
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.157

10.  Dissociation of catalytic and invasive activities of Bordetella pertussis adenylate cyclase.

Authors:  A Raptis; L Knipling; J Wolff
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.